|Chemical and physical data|
|Molar mass||g·mol−1 392.451|
|3D model (JSmol)|
5F-AB-FUPPYCA (also known as AZ-037) is a pyrazole-based synthetic cannabinoid that is presumed to be an agonist of the CB1 receptor and has been sold online as a designer drug. It was first detected by the EMCDDA as part of a seizure of 540 g white powder in France in February 2015.
The name AZ-037 is also used as a synonym for its structural isomer 5-fluoro-3,5-AB-PFUPPYCA. Thus AZ-037 is being used as a synonym for two different compounds.
- Girreser, Ulrich; Rösner, Peter; Vasilev, Andrej (July 2016). “Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted 13C NMR shifts – a case study”. Drug Testing and Analysis. 8 (7): 668–675. doi:10.1002/dta.1820. ISSN 1942-7611. PMID 26012418.
- Banister, Samuel D.; Longworth, Mitchell; Kevin, Richard; Sachdev, Shivani; Santiago, Marina; Stuart, Jordyn; Mack, James B. C.; Glass, Michelle; McGregor, Iain S.; Connor, Mark; Kassiou, Michael (27 July 2016). “Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues”. ACS Chemical Neuroscience. 7 (9): 1241–54. doi:10.1021/acschemneuro.6b00137. PMID 27421060.
- “2015. ÉVI EURÓPAI KÁBÍTÓSZER – JELENTÉS – A MONITOROZÁS 20 ÉVE” (PDF). Hungarian National Focal Point (NFP). June 2015. Retrieved 23 July 2015.
- “5-fluoro-3,5-AB-PFUPPYCA”. Cayman Chemical Company. Retrieved 11 February 2016.